Notícias e Atividades da Nanobiotix

Nanobiotix é uma das ...

• CAC All-Trade;
• SBF 120;
• TOB Iconic 10,000.

Nanobiotix é uma empresa listada sob o símbolo NANO (FR).

Veja o organograma con seus 18 executivos principais

Biografias mais buscadas da Nanobiotix

• Laurent Levy, Chief Executive Officer
• Gary Phillips, Chairman of the Board
• Alain Herrera, Director

Criar um alerta
para seguir os movimentos de executivos da Nanobiotix.

Nanobiotix possui 2.405 concorrentes concorrentes Eurofins (Luxemburgo), Lonza (Suíça) e BioNTech (Alemanha).

Popular M&A news in Biotecnologia

• IMU Biosciences acaba de anunciar uma arrecadação de fundos de 53 milhões de dólares. (publicado em 3 de junho de 2026).
• NewLimit acaba de anunciar uma arrecadação de fundos de 435 milhões de dólares. (publicado em 3 de junho de 2026).
• Rallybio and Avenzo Therapeutics have announced they will merge  (publicado em 1 de junho de 2026)..

Outros contatos sugeridos na indústria do Biotecnologia

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer da Inceptive
• Jan Van de Winkel - President and Chief Executive Officer da Genmab
• Valerie Hanote - Non-Executive Director da Eurofins

Saiba mais sobre a indústria do Biotecnologia

Últimos comunicados de imprensa de Nanobiotix

• Press Releases | Nanobiotix
• Voting Rights and Shares Capital of the Company | Nanobiotix
• NANOBIOTIX to Announce Third Quarter 2023 Operational and Financial Update on November 13, 2023 | Nanobiotix
• NANOBIOTIX Announces the Availability of a Prospectus in Connection with Capital Increases Raising Total Gross Proceeds of Approximately $50M and the Exercise by the Underwriters of the Over-Allotment Option for an Additional Amount of Approximately $3.6M
• NANOBIOTIX Announces Closing of Global Offering | Nanobiotix
• NANOBIOTIX to Present at the H.C. Wainwright 25th Annual Global Investment Conference | Nanobiotix
• NANOBIOTIX Strengthens Global Development Capabilities With the Appointment of Veteran Industry Leader Dr. Louis Kayitalire as Chief Medical Officer | Nanobiotix
• NANOBIOTIX Announces Expiration of HSR Waiting Period Regarding the Agreement for Worldwide Co-Development and Commercialization of Potential First-in-Class Radioenhancer NBTXR3 | Nanobiotix
• NANOBIOTIX to Host Extraordinary General Meeting of Shareholders on September 1st, 2023 | Nanobiotix
• Voting Rights and Shares Capital of the Company | Nanobiotix S.A.
• View more press releases Close

Redes sociais sobre Nanobiotix

• Nanobiotix na Wikipedia, Google News e Yahoo Finance
• Nanobiotix na LinkedIn, X (Twitter) e YouTube